# Dermatopharmacokinetic Trial of LEO 80185 Gel

> **NCT02605057** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 32 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** LEO 80185 gel
- **DRUG:** Dovobet(r) Ointment

## Key facts

- **NCT ID:** NCT02605057
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605057, "Dermatopharmacokinetic Trial of LEO 80185 Gel". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02605057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*